These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36966369)

  • 1. [POST-ARTEMISININ DELAYED HEMOLYSIS AFTER TREATMENT OF MALARIA].
    Baharav N; Schwartz E
    Harefuah; 2023 Mar; 162(3):143-145. PubMed ID: 36966369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria.
    Kurth F; Lingscheid T; Steiner F; Stegemann MS; Bélard S; Menner N; Pongratz P; Kim J; von Bernuth H; Mayer B; Damm G; Seehofer D; Salama A; Suttorp N; Zoller T
    Emerg Infect Dis; 2016 Aug; 22(8):1381-6. PubMed ID: 27434054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Delayed Hemolytic Anemia After Treatment with Oral Artemether-Lumefantrine in Two Patients with Severe Falciparum Malaria.
    Tsuchido Y; Nakamura-Uchiyama F; Toyoda K; Iwagami M; Tochitani K; Shinohara K; Hishiya N; Ogawa T; Uno K; Kasahara K; Ouji Y; Kano S; Mikasa K; Shimizu T; Yoshikawa M; Maruyama H
    Am J Trop Med Hyg; 2017 May; 96(5):1185-1189. PubMed ID: 28193740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemoglobin changes and risk of anaemia following treatment for uncomplicated falciparum malaria in sub-Saharan Africa.
    Zwang J; D'Alessandro U; Ndiaye JL; Djimdé AA; Dorsey G; Mårtensson AA; Karema C; Olliaro PL
    BMC Infect Dis; 2017 Jun; 17(1):443. PubMed ID: 28645255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine.
    Corpolongo A; De Nardo P; Ghirga P; Gentilotti E; Bellagamba R; Tommasi C; Paglia MG; Nicastri E; Narciso P
    Malar J; 2012 Mar; 11():91. PubMed ID: 22453057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemisinin therapy and severe delayed haemolysis.
    Jarvis JN; Coltart CE; Pule M; Chiodini PL; Doherty T
    Lancet; 2013 Jul; 382(9887):180. PubMed ID: 23849926
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence.
    Rehman K; Lötsch F; Kremsner PG; Ramharter M
    Int J Infect Dis; 2014 Dec; 29():268-73. PubMed ID: 25448338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UK malaria treatment guidelines 2016.
    Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
    J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.
    Sowunmi A; Akano K; Ayede AI; Ntadom G; Aderoyeje T; Adewoye EO; Fatunmbi B
    BMC Infect Dis; 2016 Jun; 16():240. PubMed ID: 27246468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination.
    Ouji M; Augereau JM; Paloque L; Benoit-Vical F
    Parasite; 2018; 25():24. PubMed ID: 29676250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed anemia assessment in patients treated with oral artemisinin derivatives for uncomplicated malaria: a pooled analysis of clinical trials data from Mali.
    Sagara I; Piarroux R; Djimde A; Giorgi R; Kayentao K; Doumbo OK; Gaudart J
    Malar J; 2014 Sep; 13():358. PubMed ID: 25217396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artemisinin-based combination treatment of falciparum malaria.
    Nosten F; White NJ
    Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):181-92. PubMed ID: 18165491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe delayed hemolysis associated with regulated parenteral antimalarial drug.
    Lee J; Krajden S; Graham C; Boggild AK; Pavenski K; Keystone JS; Kain KC
    Emerg Infect Dis; 2015 Jan; 21(1):164-6. PubMed ID: 25531800
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on cases of delayed hemolysis after parenteral artesunate therapy for malaria - United States, 2008 and 2013.
    Paczkowski MM; Landman KL; Arguin PM;
    MMWR Morb Mortal Wkly Rep; 2014 Aug; 63(34):753-5. PubMed ID: 25166926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible artemisinin-based combination therapy-resistant malaria in Nigeria: a report of three cases.
    Ajayi NA; Ukwaja KN
    Rev Soc Bras Med Trop; 2013; 46(4):525-7. PubMed ID: 23982103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of retreatment with an artemisinin-based combination on malaria incidence and its potential selection of resistant strains: study protocol for a randomized controlled clinical trial.
    Muhindo Mavoko H; Nabasumba C; Tinto H; D'Alessandro U; Grobusch MP; Lutumba P; Van Geertruyden JP
    Trials; 2013 Sep; 14():307. PubMed ID: 24059911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The threat of artemisinin resistant malaria in Southeast Asia.
    Hanboonkunupakarn B; White NJ
    Travel Med Infect Dis; 2016; 14(6):548-550. PubMed ID: 27915001
    [No Abstract]   [Full Text] [Related]  

  • 20. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
    Shekalaghe SA; ter Braak R; Daou M; Kavishe R; van den Bijllaardt W; van den Bosch S; Koenderink JB; Luty AJ; Whitty CJ; Drakeley C; Sauerwein RW; Bousema T
    Antimicrob Agents Chemother; 2010 May; 54(5):1762-8. PubMed ID: 20194698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.